出处
《细胞与分子免疫学杂志》
CAS
CSCD
北大核心
2008年第4期319-320,共2页
Chinese Journal of Cellular and Molecular Immunology
基金
北京协和医院重点项目基金资助(200205)
参考文献13
-
1Geissler M, Mohr L, Dohler G, et al. Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice[J]. Gastroenterology, 2001, 121 : 931 -939.
-
2Butterfield LH, Ribas A, Meng WS, et al. T-cell responses to HLA-A * 0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer [ J ]. Clin Cancer Res, 2003, 9 : 5902 - 5908.
-
3Butterfield LH, Ribas A, Dissette VB, etal. A phase I/II trial testing immunization of hepatoeellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides [ J ]. Clin Cancer Res, 2006, 12:2817-2825.
-
4Butterfield LH. Recent advances in immunothempy for hepatocellular carcinoma[J]. Swiss Med Wkly, 2007, 137:83 -90.
-
5Takayama T, Makuuchi M, Sekine T, et al. Distribution and therapeutic effect of intraarterially transferred tumor-infiltrating lymphocytes in hepatic malignancies. A preliminary report[ J]. Cancer, 1991,68: 2391 - 2396.
-
6Takayama T, Sekine T, Makuuehi M, et al. Adoptive immunothempy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial[J]. Lancet, 2000, 356:802 -807.
-
7Ladhams A, Schmidt C, Sing G, et al. Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells [J]. J Gastroenterol Hepatol, 2002, 17:889 -896.
-
8Lee WC, Wang HC, Hung CF, et al. Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial[ J]. J Immunother, 2005, 28 : 496 - 504.
-
9Wang Z, Qiu SY, Ye SL, et al. Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma [ J ]. Cancer Gene Ther, 2001, 8:751 -758.
-
10Andrews KJ, Ribas A, Butterfield LH, et al. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CDl-restricted natural killer T cells [J]. CancerRes, 2000, 60:5457 -6464.
同被引文献45
-
1Hai-XiaQin,Ke-JunNan,GuangYang,ZhaoJing,Zhi-PingRuan,Chun-LiLi,RuiXu,HuiGuo,Chen-GuangSui,Yong-ChangWei.Expression and clinical significance of TAp73α, p53, PCNA and apoptosis in hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(18):2709-2713. 被引量:12
-
2张利旺,张红梅,贾军,任军.以AFP为靶点的肝癌树突状细胞免疫治疗的实验研究[J].现代肿瘤医学,2005,13(6):736-739. 被引量:9
-
3Nakaya H.In vitro model for the suicide gene therapy of AFP producing gastric cancer using HSV tk gene under control of AFP promoter[J].Hokkaido Igaku Zasshi,2003,78 (3):203-209.
-
4Ritter M,Ali MY,Grimm CF,et al.Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma[J].J Hepatol,2004,41(6):999-1007.
-
5Butterfield LH,Ribas A,Dissette VB,et al.A phase Ⅰ/Ⅱ trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides[J].Clin Cancer Res,2006,12(9):2817-2825.
-
6Lau AH,Thomson AW.Dendritic cells and immune regulation in the liver[J].Gut,2003,52(2):307-314.
-
7Doi K,Hargitai J,Kong J,et al.Lentiviral transduction of green fluorescent protein in retinal epithelium:evidence of rejection[J].Vision Research,2002,42(4):551-558.
-
8N egre D,Mangeot PE,Duisit G,et al.Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (S IVmac251) that efficiently transduce mature human dendritic cells[J].Gene Ther,2000,7(19):1613-1623.
-
9Evans JT,Cravens P,Lipsky PE,et al.Differentiation and expansion of lentivirus vector marked dendritic cells derived from human CD34+ cells[J].Hum Gene Ther,2000,11(18):2483-2492.
-
10Arenberg DA,Zlotnick A,Strom SR,et al.The murine CC chemokine,6C-kine,inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model[J].Cancer Immunol Immunother,2001,49(11):587-692.
引证文献6
-
1李明峰,侯静,熊伟民,邸立军,任军.携带AFP基因慢病毒载体制备并感染树突状细胞的实验研究[J].细胞与分子免疫学杂志,2009,25(9):791-793. 被引量:6
-
2侯静,李明峰,熊伟民,何新颖,邸立军,任军.次级淋巴组织趋化因子和甲胎蛋白共修饰的树突状细胞诱导特异性抗肝癌免疫作用的研究[J].中国癌症杂志,2010,20(7):502-507. 被引量:4
-
3周振宇,涂康生,张竞,郑鑫,高洁,姚英民,刘青光.Fbxw7在肝癌中的表达及与肝癌细胞增殖相关性研究[J].细胞与分子免疫学杂志,2012,28(12):1303-1306. 被引量:26
-
4张竞,涂康生,周振宇,郑鑫,高洁,姚英民,刘青光.GRAMD4在肝细胞癌中的表达及临床意义[J].细胞与分子免疫学杂志,2013,29(2):190-193. 被引量:9
-
5王斐斐,于国华,刘同慎,王国艳,杨静,张光波,栾希英.可溶型B7-H3在原发性肝细胞癌患者血清中的表达及临床意义[J].细胞与分子免疫学杂志,2013,29(6):629-632. 被引量:12
-
6陈萃,李杰,郑军.DIP在肝细胞癌中的表达及其临床意义[J].中国普通外科杂志,2013,22(7):900-904.
二级引证文献56
-
1靳文剑,张焜和,陈火国,罗庆丰.β-Catenin、Skp^2和p^(27)在老年肝细胞癌中的表达及相关性[J].中国老年学杂志,2014,34(5):1173-1175. 被引量:2
-
2侯静,李明峰,熊伟民,何新颖,邸立军,任军.次级淋巴组织趋化因子和甲胎蛋白共修饰的树突状细胞诱导特异性抗肝癌免疫作用的研究[J].中国癌症杂志,2010,20(7):502-507. 被引量:4
-
3徐红梅,沈志超.医学论文中转化、转导、转染和感染的辨析[J].同济大学学报(医学版),2011,32(3):96-100.
-
4宫玉波,黄一飞,黎燕,韩根成,刘勇,王大江,杜改萍,余继锋.小鼠Foxp3基因慢病毒载体构建及其在DC2.4细胞的表达[J].细胞与分子免疫学杂志,2011,27(7):721-724. 被引量:3
-
5彭丹,王洪武.树突状细胞疫苗在抗肿瘤免疫治疗中的研究进展[J].临床肺科杂志,2012,17(11):2060-2062. 被引量:4
-
6党微旗,唐浩,曹红,王林,陈婷梅.靶向人STAT3基因的shRNA慢病毒载体的构建[J].细胞与分子免疫学杂志,2012,28(11):1204-1207. 被引量:3
-
7拓航,郑鑫,涂康生,周振宇,姚英民,刘青光.PCAF在肝细胞癌中的表达及临床意义[J].细胞与分子免疫学杂志,2013,29(3):297-300. 被引量:14
-
8曹红,王鹏举.癌胚抗原联合甲胎蛋白检测在肝癌鉴别诊断中的应用价值[J].海南医学院学报,2013,19(3):387-389. 被引量:6
-
9靳文剑,张焜和,陈火国,罗庆丰.EphA2在肝细胞癌中的表达及临床意义[J].重庆医学,2013,42(20):2361-2363. 被引量:3
-
10陈绍发.CKS1和CyclinD1在老年肝细胞癌中的表达[J].中国老年学杂志,2013,33(18):4556-4557. 被引量:3
-
1李金,徐佳,李宁,于进.肝癌免疫逃逸机制的研究成果与进展[J].中国处方药,2014,12(5):6-7. 被引量:1
-
2邱双健.树突状细胞与肝癌的免疫逃逸[J].世界华人消化杂志,2005,13(4):429-431. 被引量:8
-
3曹大勇,杨静悦,岳树强,窦科峰.重组腺病毒介导白细胞介素-18和甲胎蛋白基因修饰的树突状细胞体外诱导抗肝癌免疫活性的研究[J].中华实验外科杂志,2009,26(8):961-963. 被引量:2
-
4陈志南,刘彦仿,杨继震.抗入肝细胞癌单克隆抗体的产生及其相应抗原P60的免疫组化定位研究[J].单克隆抗体通讯,1989(2):33-36. 被引量:6
-
5林秀清,黄智铭,王剑虹,蔡勇,张豪,吴金明,吴建胜.CD4^+CD25^+FoxP3^+调节性T细胞在小鼠H22原位肝癌模型中的表达和意义[J].医学研究杂志,2013,42(10):43-47. 被引量:1
-
6夏丽洁,张富春.肝癌治疗新靶点GPC3研究进展[J].中国药理学通报,2016,32(11):1486-1489. 被引量:8
-
7张永信.延缓细菌耐药的对策[J].上海医药,2003,24(3):121-123. 被引量:4
-
8郑和鸣,蔡秀军.稳定表达人白细胞介素2肝干细胞系的建立[J].中国免疫学杂志,2010,26(4):341-344. 被引量:1
-
9赵丹洋,吴伟康.氧化应激在脑缺血损伤中的作用机制[J].中国病理生理杂志,2004,20(4):679-682. 被引量:20
-
10曹建勋,陈雪萍.脑卒中患者的家庭照顾者生活状况研究进展[J].护理学报,2010,17(19):9-11. 被引量:8